Gonorrhea: Clinical Trials

158 trials for Gonorrhea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

104 completed, 15 recruiting, 12 terminated, 10 not yet recruiting. 61 Not applicable, 23 Phase 3, 15 Phase 4, 13 Phase 2, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable61Completed 38, Recruiting 7, Not yet recruiting 6, Unknown 5, Terminated 3, Active not recruiting 1, Withdrawn 1
Phase 323Completed 10, Terminated 4, Active not recruiting 3, Not yet recruiting 2, Recruiting 2, Unknown 2
Phase 415Completed 9, Recruiting 3, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 213Completed 12, Terminated 1
Phase 111Completed 11

Follow Gonorrhea: new trials by email Literature Review of Gonorrhea trials Research Report on Gonorrhea

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
Optimizing Antibiotic Prescription in STI Clinics Using Rapid POCT
cobas® Liat® CT/NG Point-of-Care Test - Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection
Not applicableNot yet recruitingHospices Civils de Lyon4042026-12-012026-10-20
A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women
Doxycycline hyclate, Standard of Care for STI prevention - Sexually Transmitted Infection (STI), Gonorrhea
Phase 3Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)5802026-11-302026-10-20
Outcomes From Point-of-Care Sexually Transmitted Infection (STI) Testing in an Urban Sexual Health Clinic: A Randomized Trial
Point-of-care assay for chlamydia and gonorrhea, Laboratory-based chlamydia and gonorrhea NAAT, CRISPR-based assay - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection
Not applicableNot yet recruitingMassachusetts General Hospital4002026-11-012026-10-06
Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study
Venue-based, peer-enhanced strategy for integrated HIV self-testing (and self-collected STI testing - HIV, Syphilis
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill2322026-10-012026-09-18
Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections
Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml), Rectal swab for ESBL-E and microbiota (Eswab), Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) - Neisseria Gonorrhoeae (Ng) Infections
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris3602026-09-012026-06-22
Improving Maternal and Child Health Through Point-of-care STI Testing
Point-of-care STI tests, Standard of care STI testing - Treponema Pallidum Infection, Chlamydia Trachomatis Infection
Not applicableRecruitingEmory University7562026-08-112026-08-19
National Rapid TLC: Testing and Linkage to Care
Xpert® HIV-1 Qual XC - HIV, Chlamydia
Not applicableNot yet recruitingUnity Health Toronto25002026-08-012026-07-28
Metagenomic Analysis of the Pharynx in High Risk Partners
Gonorrhea, Neisseria Gonorrhea
Not yet recruitingGuy's and St Thomas' NHS Foundation Trust1002026-07-142026-06-30
500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection
ceftriaxone 500-mg, ceftriaxone 1000-mg - Gonorrhea Infection
Phase 3RecruitingNational Taiwan University Hospital4002026-07-012026-07-17
Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland
HIV (Human Immunodeficiency Virus), Chlamydia
Not yet recruitingUniversity of Zurich18002026-04-072026-04-08
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Doxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling - Gonorrhea, Chlamydia
Phase 4RecruitingWestat7602026-02-272026-10-16
Point of Care STI Testing
Gonorrhea/chlamydia Point-of-Care Testing - Point of Care STI Testing
Not applicableRecruitingIcahn School of Medicine at Mount Sinai64602026-02-242026-05-05
Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM
WHO-recommended periodic presumptive treatment, Doxycycline post-exposure prophylaxis - Gonorrhea Male, Chlamydia (Male)
Phase 4RecruitingUniversity of Washington29002025-10-292025-11-19
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Doxycycline - Sexually Transmitted Diseases, Syphilis
Not applicableRecruitingOswaldo Cruz Foundation2002025-10-282026-03-30
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
Doxycycline (200mg/day) - Syphilis Infection, Gonorrhea
Phase 4RecruitingBangrak STIs Center4002025-10-062026-02-09
Performance, Acceptability, and Usability of a Novel Rapid Lateral Flow Test for Detecting Neisseria Gonorrhoeae in Pregnant and Symptomatic Women Attending Clinics in South Africa.
Novel Lateral Flow Assay for Neisseria gonorrhoeae - Neisseria Gonorrheae Infection
RecruitingFoundation for Professional Development (Pty) Ltd12392025-09-112026-04-15
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Chlamydia, gonorrhea, syphilis, and HIV screening - Chlamydia, Gonorrhea
Not applicableRecruitingTulane University23222025-08-142026-09-21
STI Testing to Enhance PrEP Use in Pregnancy
Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing - PrEP Adherence, Sexually Transmitted Infections (STIs)
Phase 3RecruitingBotswana Harvard AIDS Institute Partnership6002025-06-182026-06-11

Showing 20 of 158. Sign in to see all of them.

Narrower conditions

Chlamydia Infections (88)  ·  Sexually Transmitted Diseases (54)  ·  Syphilis (31)  ·  HIV Infections (20)  ·  Trichomonas Infections (17)  ·  Acquired Immunodeficiency Syndrome (14)  ·  Vaginosis, Bacterial (7)  ·  Homosexuality (6)  ·  Disease (5)  ·  Infections (5)  ·  Trichomonas Vaginitis (5)  ·  Emergencies (4)  ·  Bacterial Infections (3)  ·  Communicable Diseases (3)

Broader conditions

Bacterial Infections and Mycoses (158)  ·  Genital Diseases (158)  ·  Neisseriaceae Infections (158)  ·  Urogenital Diseases (158)  ·  Gram-Negative Bacterial Infections (157)  ·  Sexually Transmitted Diseases, Bacterial (156)  ·  Bacterial Infections (155)  ·  Communicable Diseases (155)  ·  Infections (153)  ·  Sexually Transmitted Diseases (104)  ·  Chlamydiaceae Infections (88)  ·  Pathological Conditions, Signs and Symptoms (67)  ·  Pathologic Processes (66)  ·  Disease Attributes (61)  ·  Spirochaetales Infections (31)

Interventions

Ceftriaxone (15)  ·  Azithromycin (10)  ·  Doxycycline (8)  ·  4CMenB vaccine (7)  ·  Cefixime (6)  ·  Ciprofloxacin (5)  ·  zoliflodacin (5)  ·  Gentamicins (3)  ·  Standard of Care (3)  ·  gepotidacin (3)  ·  HIV Testing (2)  ·  Injections (2)  ·  Urination (2)  ·  solithromycin (2)  ·  Administration, Rectal (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (17)  ·  University of Washington (8)  ·  Northwestern University (5)  ·  University of California, San Francisco (5)  ·  University of North Carolina, Chapel Hill (4)  ·  University of Pittsburgh (4)  ·  Columbia University (3)  ·  Gen-Probe, Incorporated (3)  ·  University of California, Los Angeles (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Centers for Disease Control and Prevention (2)  ·  Chinese University of Hong Kong (2)  ·  Duke University (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  GlaxoSmithKline (2)

Countries

United States (94)  ·  France (7)  ·  South Africa (7)  ·  Australia (6)  ·  United Kingdom (5)  ·  Kenya (4)  ·  Belgium (3)  ·  Botswana (3)  ·  Malawi (3)  ·  Mexico (3)  ·  Taiwan (3)  ·  Thailand (3)  ·  Uganda (3)  ·  Austria (2)  ·  Canada (2)

Top investigators

Jim Carey, MPH (3)  ·  Julius Schachter, PhD (3)  ·  Brian Mustanski, PhD (2)  ·  Chris Kenyon, MD (2)  ·  Jeffrey D Klausner, MD, MPH (2)  ·  Jennifer Reid, PhD (2)  ·  Lindley Barbee, MD, MPH (2)  ·  Michael E Newcomb, Ph.D. (2)  ·  Ricky Hill, Ph.D. (2)  ·  Tsz Ho Kwan, PhD (2)  ·  Akshay Sharma, PhD (1)  ·  Allison K Groves, PhD, MHS (1)  ·  Anne Luetkemeyer, MD (1)  ·  Audun J Lier, MD (1)

Results publications

PMID 17301105, PMID 21099596, PMID 35710444, PMID 37018493, PMID 37351709, PMID 38118022, PMID 10582782, PMID 11386956, PMID 11880389, PMID 12392124, PMID 12593898, PMID 12904390, PMID 12958275, PMID 15937765, PMID 16314767, PMID 16314768, PMID 16455891, PMID 16825373, PMID 17051493, PMID 17077230, PMID 1777459, PMID 18038280, PMID 18532873, PMID 19023429, PMID 19104366, PMID 19220138, PMID 19321868, PMID 19389002, PMID 19549331, PMID 19591608, PMID 19616720, PMID 19649242, PMID 19936044, PMID 20072772, PMID 20308834, PMID 20335410, PMID 20370481, PMID 20585275, PMID 21124216, PMID 21173720, PMID 21216000, PMID 21489882, PMID 21775837, PMID 21949601, PMID 22082722, PMID 22421690, PMID 22728910, PMID 22882265, PMID 22927016, PMID 23107285

NIH funding

2019 (2), 1IK2CX002822-01A1 (1), 2018 (1), 2025 (1), 5UM1AI104681 (1), 5UM1AI106707 (1), 5UM1AI148576-05 (1), D43TW009340 (1), K23AI113185 (1), R01AI068107 (1), R01AI143439 (1), R01AI145971 (1), R01AI158826 (1), R01AI170564 (1), R01AI179838 (1)